Controversies in Clostridium difficile testing.

Area of Science:

• Clinical microbiology
• Infectious diseases
• Diagnostic laboratory science

Background:

• Nosocomial outbreaks of Clostridium difficile-associated disease (CDAD) have been linked to toxin A-deficient strains.
• Diagnostic assays solely detecting toxin A may misdiagnose CDAD cases caused by these emerging strains.
• Inaccurate diagnostics risk patient care and institutional outbreak management.

Purpose of the Study:

• To highlight the diagnostic challenges posed by toxin A-deficient Clostridium difficile strains.
• To emphasize the need for updated laboratory diagnostic strategies for CDAD.
• To advocate for evidence-based laboratory practices to improve diagnostic accuracy.

Main Methods:

• Review of published data on Clostridium difficile epidemiology and diagnostics.
• Analysis of laboratory testing protocols and their limitations.
• Evaluation of specimen rejection criteria for C. difficile testing.

Main Results:

• Toxin A-deficient Clostridium difficile strains are confirmed etiological agents of CDAD.
• Laboratories relying solely on toxin A detection risk significant diagnostic errors.
• Published data support the rejection of repeat stool specimens within 7 days and formed stools for C. difficile testing.

Conclusions:

• Diagnostic assays must evolve beyond toxin A detection to accurately identify all C. difficile infections.
• Implementing evidence-based specimen rejection policies can improve laboratory efficiency and reduce C. difficile testing workload.
• Updated laboratory guidelines are crucial for accurate CDAD diagnosis and effective infection control.